Veraxa Biotech Holding AG (VRXA)
CIK 2079109 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Veraxa Biotech Holding AG.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 4, 2026 | 424B3 | 0001829126-26-009754 |
| Sep 4, 2026 | 6-K | 0001829126-26-009752 |
| Sep 4, 2026 | 424B3 | 0001829126-26-009753 |
| Aug 31, 2026 | 4 | 0001829126-26-009543 |
| Aug 31, 2026 | 4 | 0001829126-26-009544 |
| Aug 24, 2026 | 6-K | 0001829126-26-009237 |
| Aug 20, 2026 | 3 | 0001829126-26-009154 |
| Aug 13, 2026 | SCHEDULE 13G/A | 0001167557-26-000206 |
| Aug 10, 2026 | 424B5 | 0001829126-26-008548 |
| Aug 10, 2026 | 424B5 | 0001829126-26-008547 |
| Aug 6, 2026 | EFFECT | 9999999995-26-002591 |
| Aug 6, 2026 | EFFECT | 9999999995-26-002577 |
| Aug 5, 2026 | F-1/A | 0001829126-26-008399 |
| Aug 5, 2026 | F-1/A | 0001829126-26-008400 |
| Jul 31, 2026 | F-1 | 0001829126-26-008246 |
| Jul 31, 2026 | F-1 | 0001829126-26-008247 |
| Jul 31, 2026 | 6-K | 0001829126-26-008238 |
| Jul 27, 2026 | 6-K | 0001829126-26-007854 |
| Jul 27, 2026 | 6-K | 0001829126-26-007881 |
| Jun 18, 2026 | 6-K | 0001829126-26-006695 |
| Jun 16, 2026 | 20-F | 0001829126-26-006546 |
| Jun 16, 2026 | SCHEDULE 13D | 0002134838-26-000001 |
| Jun 16, 2026 | SCHEDULE 13D | 0002134715-26-000001 |
| Jun 15, 2026 | SCHEDULE 13D | 0002134649-26-000001 |
| Jun 15, 2026 | SCHEDULE 13D | 0002134549-26-000001 |